S. M. Hammer, A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less, New England Journal of Medicine, vol.337, issue.11, 1997.
DOI : 10.1056/NEJM199709113371101

A. Mocroft, Changing patterns of mortality across Europe in patients infected with HIV-1, The Lancet, vol.352, issue.9142, pp.1725-1730, 1998.
DOI : 10.1016/S0140-6736(98)03201-2

F. J. Palella and . Jr, Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection, New England Journal of Medicine, vol.338, issue.13, pp.853-860, 1998.
DOI : 10.1056/NEJM199803263381301

S. Grabar, Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy, Annals of Internal Medicine, vol.133, issue.6, pp.401-410, 2000.
DOI : 10.7326/0003-4819-133-6-200009190-00007

D. M. Moore, Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy, HIV Medicine, vol.139, issue.5, pp.311-316, 2006.
DOI : 10.1310/HVQX-7Q27-X4V1-GJA1

L. Gras, CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.2, pp.183-192, 2007.
DOI : 10.1097/QAI.0b013e31804d685b

B. Rodriguez, Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection, JAMA, vol.296, issue.12, pp.1498-1506, 2006.
DOI : 10.1001/jama.296.12.1498

C. Smit, Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion, AIDS, vol.20, pp.741-749, 2006.

R. Weber, Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study, Arch. Intern. Med, vol.166, pp.1632-1641, 2006.

C. Lewden, Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The ???Mortalit?? 2000 and 2005??? Surveys (ANRS EN19 and Mortavic), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.5, pp.590-598, 2000.
DOI : 10.1097/QAI.0b013e31817efb54

W. M. El-sadr, CD4+ count-guided interruption of antiretroviral treatment, N. Engl. J. Med, vol.355, pp.2283-2296, 2006.

J. V. Baker, Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.5, pp.541-546, 2008.
DOI : 10.1097/QAI.0b013e31817bebb3

J. V. Baker, CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection, AIDS, vol.22, issue.7, pp.841-848, 2008.
DOI : 10.1097/QAD.0b013e3282f7cb76

M. D. Hazenberg, Persistent immune activation in HIV-1 infection is associated with progression to AIDS, AIDS, vol.17, issue.13, pp.1881-1888, 2003.
DOI : 10.1097/00002030-200309050-00006

P. W. Hunt, T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained research article, 2003.

S. C. Jameson, Maintaining the norm: T-cell homeostasis, Nat. Rev. Immunol, vol.2, pp.547-556, 2002.

T. J. Fry, A potential role for interleukin-7 in T-cell homeostasis, Blood, vol.97, issue.10, pp.2983-2990, 2001.
DOI : 10.1182/blood.V97.10.2983

K. H. Grabstein, Inhibition of murine B and T lymphopoiesis in vivo by an anti- interleukin 7 monoclonal antibody, Journal of Experimental Medicine, vol.178, issue.1, pp.257-264, 1993.
DOI : 10.1084/jem.178.1.257

R. Murray, T. Suda, N. Wrighton, F. Lee, and A. Zlotnik, IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets, International Immunology, vol.1, issue.5, pp.526-531, 1989.
DOI : 10.1093/intimm/1.5.526

A. Puel, S. F. Ziegler, R. H. Buckley, L. , and W. J. , Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency, Nat. Genet, vol.20, pp.394-397, 1998.

U. Von-freeden-jeffry, Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine, Journal of Experimental Medicine, vol.181, issue.4, pp.1519-1526, 1995.
DOI : 10.1084/jem.181.4.1519

K. S. Schluns, W. C. Kieper, S. C. Jameson, and L. Lefrancois, Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo, Nature Immunology, vol.1, issue.5, pp.426-432, 2000.
DOI : 10.1038/80868

C. L. Mackall, IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation, Blood, vol.97, issue.5, pp.1491-1497, 2001.
DOI : 10.1182/blood.V97.5.1491

L. Vassena, M. Proschan, A. S. Fauci, and P. Lusso, Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals, Proceedings of the National Academy of Sciences, vol.104, issue.7, pp.2355-2360, 2007.
DOI : 10.1073/pnas.0610775104

J. Lelievre, A. Berry, and F. Benoit-vical, Artemisinin and chloroquine: do mode of action and mechanism of resistance involve the same protagonists?, Curr. Opin. Investig. Drugs, vol.8, pp.117-124, 2007.

A. Malaspina, Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7, Proceedings of the National Academy of Sciences, vol.103, issue.7, pp.2262-2267, 2006.
DOI : 10.1073/pnas.0511094103

S. Kimmig, Two Subsets of Naive T Helper Cells with Distinct T Cell Receptor Excision Circle Content in Human Adult Peripheral Blood, The Journal of Experimental Medicine, vol.163, issue.6, pp.789-794, 2002.
DOI : 10.1073/pnas.97.16.9203

T. J. Fry, IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates, Blood, vol.101, issue.6, pp.2294-2299, 2003.
DOI : 10.1182/blood-2002-07-2297

C. Sportes, Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, The Journal of Experimental Medicine, vol.153, issue.7, pp.1701-1714, 2008.
DOI : 10.1016/0198-8859(96)00076-6

J. F. Purton, C. E. Martin, and C. D. Surh, Enhancing T cell memory: IL-7 as an adjuvant to boost memory T-cell generation, Immunology and Cell Biology, vol.175, issue.5, pp.385-386, 2008.
DOI : 10.1126/science.1122927

S. G. Nanjappa, J. H. Walent, M. Morre, and M. Suresh, Effects of IL-7 on memory CD8+ T cell homeostasis are influenced by the timing of therapy in mice, Journal of Clinical Investigation, vol.118, pp.1027-1039, 2008.
DOI : 10.1172/JCI32020

N. Schmitt, Positive Regulation of CXCR4 Expression and Signaling by Interleukin-7 in CD4+ Mature Thymocytes Correlates with Their Capacity To Favor Human Immunodeficiency X4 Virus Replication, Journal of Virology, vol.77, issue.10, pp.5784-5793, 2003.
DOI : 10.1128/JVI.77.10.5784-5793.2003

M. D. Smithgall, J. G. Wong, K. E. Critchett, and O. K. Haffar, IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells, J. Immunol, vol.156, pp.2324-2330, 1996.

L. Chene, Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7, 1999.

M. M. Lederman and H. Valdez, Immune Restoration With Antiretroviral Therapies, JAMA, vol.284, issue.2, pp.223-228, 2000.
DOI : 10.1001/jama.284.2.223

L. Teixeira, Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function, AIDS, vol.15, issue.14, pp.1749-1756, 2001.
DOI : 10.1097/00002030-200109280-00002

C. J. Smith, Factors Influencing Increases in CD4 Cell Counts of HIV???Positive Persons Receiving Long???Term Highly Active Antiretroviral Therapy, The Journal of Infectious Diseases, vol.190, issue.10, pp.1860-1868, 2004.
DOI : 10.1086/425075

J. P. Viard, Influence of age on CD4 cell recovery in human immunodeficiency virusinfected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study, 2001.

E. Florence, Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study, HIV Medicine, vol.133, issue.3, pp.255-262, 2003.
DOI : 10.1097/00002030-200012220-00006

D. C. Douek, Changes in thymic function with age and during the treatment of HIV infection, Nature, vol.396, pp.690-695, 1998.

G. R. Kaufmann, Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/??L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy, Clinical Infectious Diseases, vol.41, issue.3, pp.361-372, 2005.
DOI : 10.1086/431484

J. A. Kovacs, Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection ??? A Preliminary Study, New England Journal of Medicine, vol.332, issue.9, pp.567-575, 1995.
DOI : 10.1056/NEJM199503023320904

R. G. Kovacs and S. M. Aguayo, Images in clinical medicine. Superior vena cava syndrome, N. Engl. J. Med, vol.329, p.1007, 1993.

Y. Levy, Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, The Lancet, vol.353, issue.9168, pp.1923-1929, 1999.
DOI : 10.1016/S0140-6736(98)07345-0

Y. Levy, Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection, AIDS, vol.17, issue.3, pp.343-351, 2003.
DOI : 10.1097/00002030-200302140-00008

S. Beq, IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy, The Journal of Immunology, vol.176, issue.2, pp.914-922, 2006.
DOI : 10.4049/jimmunol.176.2.914

URL : https://hal.archives-ouvertes.fr/pasteur-00023330

J. Storek, Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys, Blood, vol.101, issue.10, pp.4209-4218, 2003.
DOI : 10.1182/blood-2002-08-2671

S. A. Rosenberg, IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells, Journal of Immunotherapy, vol.29, issue.3, pp.313-319, 2006.
DOI : 10.1097/01.cji.0000210386.55951.c2

F. X. Wang, IL-7 is a potent and proviral strain???specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART, Journal of Clinical Investigation, vol.115, issue.1, pp.128-137, 2005.
DOI : 10.1172/JCI200522574

K. S. Schluns and L. Lefrancois, Cytokine control of memory T-cell development and survival, Nature Reviews Immunology, vol.3, issue.4, pp.269-279, 2003.
DOI : 10.1038/nri1052

S. M. Kaech, Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells, Nature Immunology, vol.4, issue.12, pp.1191-1198, 2003.
DOI : 10.1038/ni1009

C. Carini, M. F. Mclane, K. H. Mayer, and M. Essex, Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection, European Journal of Immunology, vol.16, issue.12, pp.2927-2934, 1994.
DOI : 10.1002/eji.1830241202

M. Paiardini, Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals, The Journal of Immunology, vol.174, issue.5, pp.2900-2909, 2005.
DOI : 10.4049/jimmunol.174.5.2900

C. M. Mastroianni, Circulating Levels of Interleukin-7 in Antiretroviral-Na??ve and Highly Active Antiretroviral Therapy-Treated HIV-Infected Patients, HIV Clinical Trials, vol.88, issue.2, pp.108-112, 2001.
DOI : 10.1086/314572

A. Llano, Interleukin-7 in Plasma Correlates with CD4 T-Cell Depletion and May Be Associated with Emergence of Syncytium-Inducing Variants in Human Immunodeficiency Virus Type 1-Positive Individuals, Journal of Virology, vol.75, issue.21, pp.10319-10325, 2001.
DOI : 10.1128/JVI.75.21.10319-10325.2001

L. A. Napolitano, Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis, Nat. Med, vol.7, pp.73-79, 2001.

S. C. Sasson, Increased Plasma Interleukin???7 Level Correlates with Decreased CD127 and Increased CD132 Extracellular Expression on T Cell Subsets in Patients with HIV???1 Infection, The Journal of Infectious Diseases, vol.193, issue.4, pp.505-514, 2006.
DOI : 10.1086/499309

R. M. Dunham, CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection, The Journal of Immunology, vol.180, issue.8, pp.5582-5592, 2008.
DOI : 10.4049/jimmunol.180.8.5582

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683429

G. Silvestri and M. B. Feinberg, Turnover of lymphocytes and conceptual paradigms in HIV infection, Journal of Clinical Investigation, vol.112, issue.6, pp.821-824, 2003.
DOI : 10.1172/JCI19799

J. M. Mccune, The dynamics of CD4+ T-cell depletion in HIV disease, Nature, vol.20, issue.6831, pp.974-979, 2001.
DOI : 10.1038/35073648

D. C. Douek, Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution, The Lancet, vol.355, issue.9218, pp.1875-1881, 2000.
DOI : 10.1016/S0140-6736(00)02293-5

O. Ducrey-rundquist, M. Guyader, and D. Trono, Modalities of Interleukin-7-Induced Human Immunodeficiency Virus Permissiveness in Quiescent T Lymphocytes, Journal of Virology, vol.76, issue.18, pp.9103-9111, 2002.
DOI : 10.1128/JVI.76.18.9103-9111.2002

D. D. Scripture-adams, D. G. Brooks, Y. D. Korin, Z. , and J. A. , Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype, Journal of Virology, vol.76, issue.24, pp.13077-13082, 2002.
DOI : 10.1128/JVI.76.24.13077-13082.2002

V. Avettand-fenoel, F. Boufassa, J. Galimand, L. Meyer, R. et al., HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is, Journal of Clinical Virology, vol.42, issue.4, pp.399-404, 2008.
DOI : 10.1016/j.jcv.2008.03.013

. Agence-nationale-de-recherches-sur-le-sida-et-les-hépatites-virales, ANRS scale to grade the severity of adverse events in adults, 2008.

M. Losso, D. Abrams, I. Esprit-study, and . Group, Effect of interleukin-2 on clinical outcomes in patients with a CD4+ cell count of 300/mm3: primary results of the ESPRIT study, Abstract no. 90aLB presented at the 16th Conference on Retroviruses and Opportunistic Infections, pp.8-11, 2009.

Y. Levy, Effect of interleukin-2 on clinical outcomes in patients with CD4+ cell count 50 to 299/mm3: primary results of the SILCAAT study, Abstract no. 90bLB presented at the 16th Conference on Retroviruses and Opportunistic Infections, 2009.